New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Revolution Medicines, Inc.
RVMD
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

8B

Biotechnology

Next Earning date - 24 Feb 2025

8B

Biotechnology

Next Earning date - 24 Feb 2025

41.32USD

Shape-0.68 ( -1.62%)
Market Closed (as of Feb 13, 22:18 EDT)
favorite-chart

Relative Strenght

60
favorite-chart

Volume Buzz

-29%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

34%

Quote Panel

Shape
Updated February 14, 2025
1W -1.76 % 1M 3.40 % 3M -25.05 % 1Y 40.16 %

Key Metrics

Shape
  • Market Cap

    7.53B


  • Shares Outstanding

    182.35M


  • Share in Float

    154.17M


  • Dividende

    0


  • Earning Date

    24 Feb 2025


  • Price Target

    41.32


  • Average Volume

    1.56M


  • Beta

    1.404


  • Range

    28.43-62.4


  • Industry

    Biotechnology


  • Website

    https://www.revmed.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

RVMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$6M

ShapeNaN%

2025-Revenue

$3.96

Shape-321%

2025-EPS

$6M

Shape97%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

71.00(71.83%)

Number of analyst

1

Last analyst upgrade/downgrade

Piper Sandler

downgrade

Previous: Overweight

2024-07-16

Now: Neutral

Barclays

initialise

Previous: Not converted

2024-07-12

Now: Overweight

Jefferies

initialise

Previous: Not converted

2024-07-08

Now: Buy

Raymond James

upgrade

Previous: Not converted

2024-04-10

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.63
vs -0.71

Q1.23

arrow
arrow

N/A

-0.72
vs -0.78

Q2.23

arrow
arrow

N/A

-0.92
vs -0.82

Q3.23

arrow
arrow

N/A

-0.99
vs -0.87

Q4.23

arrow
arrow

N/A

-1.14
vs -0.63

Q1.24

arrow
arrow

N/A

-0.70
vs -0.72

Q2.24

arrow
arrow

N/A

-0.81
vs -0.92

Q3.24

arrow
arrow

N/A

-0.94
vs -0.99

Q4.24

arrow
arrow

N/A

-0.99
vs -1.14

Q1.25

arrow
arrow

N/A

-0.93
vs -0.70

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+62%

15.3M  vs 9.5M

Q1.23

arrow
arrow

-7%

7M  vs 7.6M

Q2.23

arrow
arrow

-58%

3.8M  vs 9.1M

Q3.23

arrow
arrow

-100%

NA  vs 3.4M

Q4.23

arrow
arrow

-95%

742K  vs 15.3M

Q1.24

arrow
arrow

-100%

NA  vs 7M

Q2.24

arrow
arrow

-100%

NA  vs 3.8M

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-49%

375K  vs 742K

Q1.25

arrow
arrow

NA

1.2M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-8%

-0.08
vs -0.11

Q1.23

arrow
arrow

-6%

-0.06
vs -0.08

Q2.23

arrow
arrow

-11%

-0.11
vs -0.06

Q3.23

arrow
arrow

-13%

-0.13
vs -0.11

Q4.23

arrow
arrow

-9%

-0.09
vs -0.13

Q1.24

arrow
arrow

-7%

-0.07
vs -0.09

Q2.24

arrow
arrow

-8%

-0.08
vs -0.07

Q3.24

arrow
arrow

-10%

-0.10
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

153

153
vs 140

9%

Q2.23

arrow
arrow

146

146
vs 153

-5%

Q3.23

arrow
arrow

185

185
vs 146

27%

Q4.23

arrow
arrow

201

201
vs 185

9%

Q1.24

arrow
arrow

220

220
vs 201

9%

Q2.24

arrow
arrow

228

228
vs 220

4%

Q3.24

arrow
arrow

262

262
vs 228

15%

Q4.24

arrow
arrow

98

98
vs 262

-63%

Earnings Growth

Latest News